Business Blockbuster - Helpng business to be more visible on Google

Business Daily Media


.

AIM Vaccine mRNA RSV Vaccine Submits for Clinical Trials in the U.S.

Multiple Institutions Give AIM a "Buy" Rating

HONG KONG SAR - Media OutReach Newswire – 5 February 2025 - AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to the U.S.

Food and Drug Administration (FDA). The vaccine has demonstrated significantly higher humoral and cellular immunity compared to internationally marketed products. If the product progresses smoothly, it will accelerate AIM Vaccine's international expansion and contribute to substantial performance growth.

In preclinical animal trials, third-party testing results showed that AIM Vaccine's mRNA RSV vaccine achieved significantly higher levels of specific IgG antibody titers, live-virus neutralizing antibody potency, and specific T-cell immunity compared to internationally marketed mRNA RSV control vaccines.

This announcement highlights AIM Vaccine's innovative capabilities and underscores the acceleration of its internationalization efforts, which have been recognized by multiple institutions.

Recently, FOSUN INTERNATIONAL SECURITIES initiated coverage of AIM Vaccine, assigning a "Buy" rating with a 12-month target price of HKD 11.0. The report cited the company's strong product pipeline, technological leadership, and potential for international growth as key factors. Similarly, SDICSI released a research report predicting that AIM Vaccine will launch 1-2 products annually over the next three years. If the products in development gain approval and progress smoothly in international markets, they are expected to drive new performance growth and expand market potential. SDICSI also assigned a "Buy" rating with a target price of HKD 9.5.

FOSUN INTERNATIONAL SECURITIES's analysis indicates that the Chinese vaccine market is evolving in line with global trends, where high-value products and leading companies dominate. With its differentiated advantages, AIM Vaccine is poised to secure a leading position in the domestic market while achieving scalable expansion internationally. Additionally, the company's comprehensive and iterative product portfolio is expected to enhance its market share, pricing power, and profitability, further supporting long-term growth.

The report also emphasized that AIM Vaccine, with its diversified product portfolio, technological strengths, and global expansion strategy, presents an attractive investment opportunity for investors. With a series of high-value products set to launch and profitability expected to rebound from 2025 onwards, the company is positioned for strong growth and potential valuation reassessment.

Globally, there are currently no approved antiviral drugs for RSV available for clinical use. Vaccination for active immune prophylaxis remains the most effective means to prevent severe RSV infections. No RSV vaccines have been approved for marketing in PRC. In 2023, global sales of RSV vaccines reached USD 2.46 billion, and according to industry consultants, the market size is expected to grow to approximately USD 16.7 billion by 2030.

The mRNA vaccine field is still wide open with plenty of opportunities, as there are few competitors globally. AIM Vaccine is one of the earliest companies in PRC to develop mRNA vaccine products and is among the first domestic vaccine enterprises to obtain independent patents for mRNA technology. The company has established a mature mRNA vaccine R&D system and has developed multiple mRNA candidate vaccines, including vaccines for shingles, rabies, and influenza, in addition to the mRNA RSV vaccine.
Hashtag: #AIMVaccine

The issuer is solely responsible for the content of this announcement.

News from Asia

EBANX and Eneba strengthen partnership in Latin America with 138% YoY growth in payment volume

With Pix, Nequi, and Mercado Pago among the most used payment methods by Eneba’s customers, the operation now covers eight countries in the regionCURITIBA, BRAZIL – Media OutReach Newswire – 13 No...

L’OCCITANE Celebrates 50 Years Of Provençal Craftsmanship With Holiday 2026 Collection

Featuring a creative collaboration with artist Caroline Romain-Desfossés, the Maison marks its golden milestone with a festive collection inspired by the art of gifting. KUALA LUMPUR, MALAYSIA – ...

Yicura BioMed Advances Dual Capital and Industrial Strategy: Completes First Closing of Series B Financing Led by Gobi Partners

Advancing Core Product ICVAX® for HIV & Immunotherapy Pipeline for CancersHONG KONG SAR – Media OutReach Newswire – 13 November 2026 – Yicura BioMed ("Yicura"), a clinical-stage immunotherapy ...

LOCUS-T and My Starfish Foundation Launch Illustrated Cancer Book to Make Cancer Information More Accessible

SHAH ALAM, MALAYSIA – Media OutReach Newswire – 13 November 2026 – Malaysian digital marketing agency LOCUS-T has joined hands with My Starfish Foundation (MSF) to launch What Do We Do Next? ...

From Message to Mandate: PRISM Summit 2026 Calls on Communicators to Claim Their Seat at the Governance Table

Inaugural Singapore State of PR and Communications Survey unveiled as senior communicators, journalists and board leaders gather at METT SingaporeSINGAPORE – Media OutReach Newswire – 13 November ...

Former Tencent Cloud AI Executive Eric Muqing Li Appointed Co-CEO of Education AI Company Qimingdaren

CHENGDU, CHINA – Media OutReach Newswire – 13 November 2026 – According to a report by Leiphone, Eric Muqing Li, formerly Head of Global Business at Tencent Cloud AI, has recently been appointed C...

Chongqing: Forging New Connections Across Eurasia — Industry Matchmaking Conference of Chongqing Visit by Eurasian Enterprises Held

CHONGQING, CHINA - Media OutReach Newswire - 13 November 2026 - On November 12, the Industry Matchmaking Conference of Chongqing Visit by Eurasian Enterprises was held at Yuzhou Hotel. Around 700 ...

Bora Group 3Q26: Revenue and Net Income Expansion Continues U.S. Manufacturing and Biologics Footprint Complete; Margin Expansion to Follow as Utilization Improves

HONG KONG SAR – Media OutReach Newswire – 13 November 2026 – Bora Pharmaceuticals ("Bora"; TWSE: 6472; OTCQX: BORAY) today announced its financial results and operational highlights for 3Q2026 an...

CALL-E Lets AI Agents in ChatGPT, Muse and OpenClaw Make Real Phone Calls on Their Users' Behalf

Built by AI Rudder, CALL-E asks the user before every call and reports back with proof of what was agreed.SAN FRANCISCO, US – Media OutReach Newswire – 13 November 2026 – AI Rudder, the Singapore-...

11 Boutique Xinjiang Wineries to Debut in Singapore

The launch programme includes a one-day trade exhibition, Master of Wine masterclass and Michelin-starred pairing dinner, highlighting Xinjiang terroir.SINGAPORE - Media OutReach Newswire - 14 Nov...

Why the secrecy around car insurance?

Every year, millions of Australians receive their car insurance renewal and promise themselves they’ll look at it properly later. Then life gets in ...

Australian workers spend almost an hour a day administering email

Research finds email filing, searching and rework consuming an estimated 58 minutes a day and potentially exposing organisations to millionsAustralian...

Customer Service Is Becoming Part of the Small Business Sales and Marketing Engine

For Customer Service Week, 5-9 October, Thryv is urging small businesses to look beyond generating  enquiries and examine what happens after a custome...

Gift Cards as the gateway to agentic payments

Prepaid and stored value gives consumers the trust and control to try AI shopping agents By Blackhawk Network VP Head of ANZ Kieran Nolan For deca...

Why Data Accumulation Without Governance Undermines Sustainability Goals

In July 2026, Group 2 entities, the second cohort of Australian businesses, began their first reporting period under the mandatory climate disclosur...

Permanent $20,000 Instant Asset Write-Off Gives Small Businesses Greater Planning Certainty

The Federal Government’s decision to permanently legislate the $20,000 instant asset write-off will give eligible small businesses greater certainty...